CLINICAL_TRIALS
trial_result
· 2017-11-13
Clinical Trial Update: TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) [Phase 2]
Summary
A Phase 2 trial of TRX4 monoclonal antibody for Type 1 diabetes was terminated. The results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED | Results posted: 2017-11-13